CR
CRL
-2.0%⚪ No clear catalystCharles River Laboratories · Healthcare
$300.15Vol 674.8K · 0.7× normalMkt cap −$0.29BMarket closed — 2026-10-16 session
What happened
Move
-2.0%
Price
$300.15
Volume
674.8K
0.7× normal
Market cap
$14.33B
−$0.29B today
Why it moved
Sector-wide movelow confidence
- Sector-wide move — computed
- Charles River partners with Magellan Stem Cells on cell therapy — finnhub-news
Sector-driven move — the stock is moving largely with its sector (-1.1%); no major company-specific catalyst detected.
Verdict — was the move justified?
⚪ No clear catalyst
No reliable catalyst was identified for this move.
How unusual is this move
σ score
1.0σ
vs own 20d volatility
Percentile
65th
of 1278 daily moves
Avg daily move
±1.9%
own 5y average
vs sector
-0.8%
beyond sector median
Fundamental context
V 55G 6P 17H 45Q 65EW 30/65
Insider activity (90d): net selling $11.13M
Valuation context
P/E (TTM)
19.0
5y median 24.7
P/E percentile
2%
vs own 4y history
FCF yield
0.1%
Trading cheaper than 98% of its own historical valuation range.
Full fundamental analysis on PreMarketPrice
Pillar scores, financial statements, valuation history, news & more for CRL